Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

China · Delayed Price · Currency is CNY

9.45

+0.23 (2.49%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Raw Materials and Intermediates	757.52M					307.91M	243.89M	240.19M	198.84M
Raw Materials and Intermediates Growth	-					26.25%	1.54%	20.79%	-24.30%
Fees for Technical Services	37.76M					-	-	-	-
Total	795.29M					307.91M	243.89M	240.19M	198.84M
Total Growth	-					26.25%	1.54%	20.79%	-24.30%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	333.11M					-	-	-	-
Export	462.18M					-	-	-	-
Total	795.29M					-	-	-	-

Source: S&P Global Market Intelligence.